UW-Madison spinouts receive SBIR funding to advance technologies

Since 2014, the Wisconsin Economic Development Corporation, in collaboration with the University of Wisconsin-Extension’s Center of Technology Commercialization, has provided nearly $8.8 million in SBIR matching-grants to 111 Wisconsin tech businesses. Several UW spinouts recently received $100k in SBIR funding to advance their technologies, including:

  • AmebaGone: Dr. Marcin Filutowicz and Katarzyna Borys from the Bacteriology Department of University of Wisconsin-Madison conceived the core technology, and Dr. Filutowics founded AmebaGone in 2010.
  • Imbed Biosciences: Ankit Agarwal was part of a team that invented the technology while he was a post-doctoral research scientist at the UW-Madison in 2008. The team also included Jonathan McAnulty, chairman of the Department of Surgical Sciences at the UW-Madison School of Veterinary Medicine, and former UW surgeon Dr. Michael Schurr, now a surgeon at Mission Hospitals.
  • Stem Pharm: the company was co-founded by Professor of Biomedical Engineering and Orthopedics Bill Murphy.
Read the full article at: https://www.bizjournals.com/milwaukee/inno/stories/fundings/2020/09/29/six-wisconsin-companies-awarded-100-k-each-in-sbir.html